Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Supplements for Controlling Resistance to Insulin

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
状態終了しました
スポンサー
University of Southern California
共同編集者
InterHealth Nutraceuticals, Inc.

キーワード

概要

The purpose of this study is to evaluate the effects of a combination of hydroxcycitrate (HCA) and niacin-bound chromium, in conjunction with nutrition education, over a twelve week period. Participants will be evaluated with regard to BMI, percent body fat, insulin activity, and hunger.

説明

The prevalence of obesity among youth has increased dramatically in recent years. Parallel to the increased rates of pediatric obesity, overweight children present clinically with adiposity related comorbidities such as insulin resistance and type 2 diabetes. The prevailing recommendations for overweight youth are to increase physical activity levels and limit energy intake in order to improve body composition. Currently there is little empirical evidence to support the efficacy of these recommendations. Alternatively, evidence in adults suggests that nutritional supplementation with (-) hydroxycitric acid (HCA), an organic acid found naturally in citrus fruits, and chromium may lead to favorable changes in body composition and improve glucose regulation. To date, these issues have not been tested in youth. Therefore, the purpose of the present investigation is to examine the effects of a nutritional education program combined with either HCA + chromium or placebo on measures of body composition and glucose regulation in overweight adolescents.

日付

最終確認済み: 04/30/2019
最初に提出された: 06/15/2008
提出された推定登録数: 06/16/2008
最初の投稿: 06/17/2008
最終更新が送信されました: 05/30/2019
最終更新日: 06/24/2019
最初に提出された結果の日付: 09/22/2011
最初に提出されたQC結果の日付: 03/28/2017
最初に投稿された結果の日付: 05/10/2017
実際の研究開始日: 01/31/2008
一次完了予定日: 07/31/2008
研究完了予定日: 07/31/2008

状態または病気

Obesity
Diabetes Mellitus, Type 2

介入/治療

Drug: 1 - nutrition education plus active supplement

Drug: 2 - nutrition education plus inactive supplement

段階

段階 4

アームグループ

介入/治療
Active Comparator: 1 - nutrition education plus active supplement
nutrition education plus active supplement
Drug: 1 - nutrition education plus active supplement
After all baseline measures have been completed, participants will be randomly assigned to either the nutrition education + supplement group, or the nutrition education + placebo group. The length of the intervention is twelve weeks. Nutrition classes will take place once a week for 1 1/2 hours. Subjects will be encouraged to increase fiber and decrease sugar intake. They will also be separated into gender-specific classes. Active and inactive supplements will be identical in appearance and taste. Active supplements will contain 2,700 mgs/day of Super CitriMax (hydroxycitrate)and 400 µg per day of ChromeMate (niacin-bound Chromium). Supplements will be in powder and tablet form, and should be taken 30 minutes prior to each meal.
Placebo Comparator: 2 - nutrition education plus inactive supplement
nutrition education plus inactive supplement
Drug: 2 - nutrition education plus inactive supplement
After all baseline measures have been completed, participants will be randomly assigned to either the nutrition education + supplement group, or the nutrition education + placebo group. The length of the intervention is twelve weeks. Nutrition classes will take place once a week for 1 1/2 hours. Subjects will be encouraged to increase fiber and decrease sugar intake. They will also be separated into gender-specific classes. Active and inactive supplements will be identical in appearance and taste.

適格基準

研究の対象となる年齢 13 Years に 13 Years
研究に適格な性別All
健康なボランティアを受け入れるはい
基準

Inclusion Criteria:

- Age

- All subjects will be between 13 and 17 years of age

- Overweight

- All subjects will be overweight as defined by an age & sex-specific body mass index ≥ 85th percentile based on CDC BMI growth charts [US Department of Health and Human Services, 2000], calculated by Epi Info Software, version 3.3.

Exclusion Criteria:

- Presently taking any prescribed medication(s) or diagnosed with any syndrome or disease that could influence dietary intake, body composition and fat distribution, or insulin action or secretion.

- Previously diagnosed with any major illness since birth (e.g. sever intrauterine growth retardation, chronic birth asphyxia, cancer).

- Children with type 1 and/or type 2 diabetes will be excluded are referred to a physician.

- Currently involved with any dietary, exercise, or weight loss program or have been in the 6 months prior to participation.

- Unexplained weight loss or gain in the prior six months.

- Oral contraception use in sexually active females

- Children who live further than 20 miles away from the USC Health Science Campus (HSC).

結果

主な結果の測定

1. Body Mass Index [measured at baseline and 12 weeks]

Change in Body Mass Index measurement at baseline and 12 weeks

二次的な結果の測定

1. Insulin Activity [Measured at baseline and 12 weeks]

Change in insulin activity measured at baseline and 12 weeks

2. Percent Body Fat [Measured at baseline and 12 weeks]

Change in percent body fat measured at baseline and 12 weeks

3. Hunger [Measured at baseline and 12 weeks]

Change in hunger score measured at baseline and 12 weeks

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge